TOAST clinical trial for babies born with the birth defect oeasophageal atresia

Published on Monday, 01 March 2021 Tweet

Researchers from the NPEU are helping to coordinate a new large-scale study called Treating Oesophageal Atresia to prevent STricture (TOAST). The study will investigate whether antacid medications help or hinder treatment of babies born with oesophageal atresia (OA), a severe birth defect.

For more information, please read the NDPH news article Major new 'Gold Standard' trial aims to help improve treatment for babies born with oesophageal atresia